{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:06:15Z","timestamp":1761919575275,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.clml.2012.05.003","type":"journal-article","created":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T02:08:18Z","timestamp":1338516498000},"page":"366-374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Risk Stratification of Plasma Cell Neoplasm: Insights From Plasma Cell\u2013Specific Cytoplasmic Immunoglobulin Fluorescence in Situ Hybridization (cIg FISH) vs. Conventional FISH"],"prefix":"10.1016","volume":"12","author":[{"given":"Henry","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Su","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundar","family":"Jagannath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine F.","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Brenholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitabha","family":"Mazumder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajai","family":"Chari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2012.05.003_bib1","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.2005.04.242","article-title":"International staging system for multiple myeloma","volume":"23","author":"Greipp","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2012.05.003_bib2","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1182\/blood-2005-05-1981","article-title":"Relationship of patient survival and chromosome anomalies detected in metaphase and\/or interphase cells at diagnosis of myeloma","volume":"106","author":"Dewald","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib3","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","article-title":"Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du My\u00e9lome","volume":"109","author":"Avet-Loiseau","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib4","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3324\/haematol.2009.016436","article-title":"Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the international staging system classification allows stratification of myeloma patients undergoing autologous stem cell transplantation","volume":"95","author":"Neben","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2012.05.003_bib5","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1038\/leu.2009.174","article-title":"International Myeloma Working Group molecular classification of multiple myeloma: spotlight review","volume":"23","author":"Fonseca","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.05.003_bib6","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1182\/blood-2010-10-300970","article-title":"Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2","volume":"117","author":"Munshi","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib7","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJMoa0801479","article-title":"Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma","volume":"359","author":"San Miguel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clml.2012.05.003_bib8","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/blood-2009-01-202010","article-title":"Impact of risk stratification on outcome among patients with multiple myeloma receiving initial therapy with lenalidomide and dexamethasone","volume":"114","author":"Kapoor","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1182\/blood-2008-12-193458","article-title":"Influence of cytogenetics in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone: adverse effect of deletion 17p13","volume":"114","author":"Reece","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(09)70284-0","article-title":"Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial","volume":"11","author":"Rajkumar","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clml.2012.05.003_bib11","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1200\/JCO.2010.28.3945","article-title":"Bortezomib plus dexamethasone induction improves outcome of patients with t(4;14) myeloma but not outcome of patients with del(17p)","volume":"28","author":"Avet-Loiseau","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2012.05.003_bib12","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1182\/blood-2011-01-270140","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategies","volume":"117","author":"Korde","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib13","first-page":"5640","article-title":"High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies","volume":"58","author":"Avet-Loiseau","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2012.05.003_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.0.CO;2-X","article-title":"Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations","volume":"18","author":"Calasanz","year":"1997","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clml.2012.05.003_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-4608(99)00009-6","article-title":"Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma","volume":"113","author":"Rajkumar","year":"1999","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2012.05.003_bib16","first-page":"2109","article-title":"Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma","volume":"9","author":"Flactif","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.05.003_bib17","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1182\/blood.V91.9.3366","article-title":"Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes","volume":"91","author":"P\u00e9rez-Sim\u00f3n","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1098-2264(199901)24:1<9::AID-GCC2>3.0.CO;2-K","article-title":"High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization","volume":"24","author":"Avet-Loiseau","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.clml.2012.05.003_bib19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1200\/JCO.2000.18.4.804","article-title":"Predictive role of interphase cytogenetics for survival of patients with multiple myeloma","volume":"18","author":"K\u00f6nigsberg","year":"2000","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.clml.2012.05.003_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF03165090","article-title":"Cytogenetic and FISH studies in myelodysplasia, acute myeloid leukemia, chronic lymphocytic leukemia and lymphoma","volume":"76","author":"Dewald","year":"2002","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clml.2012.05.003_bib21","first-page":"300","article-title":"Detection of 13q abnormalities in multiple myeloma using immunomagnetically selected plasma cells","volume":"49","author":"Fiserov\u00e1","year":"2002","journal-title":"Neoplasma"},{"key":"10.1016\/j.clml.2012.05.003_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cancergencyto.2005.02.015","article-title":"High incidence and intraclonal heterogeneity of chromosome 11 aberrations in patients with newly diagnosed multiple myeloma detected by multiprobe interphase FISH","volume":"161","author":"Cremer","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2012.05.003_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-4608(97)00058-7","article-title":"A novel three-color, clone-specific fluorescence in situ hybridization procedure for monoclonal gammopathies","volume":"101","author":"Ahmann","year":"1998","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2012.05.003_bib24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/sj.leu.2402125","article-title":"Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomy","volume":"15","author":"Fonseca","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.05.003_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2004.04867.x","article-title":"The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant","volume":"125","author":"Chang","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2012.05.003_bib26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3324\/haematol.13369","article-title":"Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis","volume":"94","author":"Bryce","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2012.05.003_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.leu.2404442","article-title":"Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials","volume":"21","author":"Jagannath","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.05.003_bib28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.leu.2404459","article-title":"Bortezomib in relapsed multiple myeloma: response rates and duration of response are independent of a chromosome 13q-deletion","volume":"21","author":"Sagaster","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.05.003_bib29","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.leukres.2006.08.002","article-title":"Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed\/refractory multiple myeloma","volume":"31","author":"Chang","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2012.05.003_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2141.2009.07864.x","article-title":"TP53 deletion is not an adverse feature in multiple myeloma treated with total therapy 3","volume":"147","author":"Shaughnessy","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2012.05.003_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/10428190009065839","article-title":"Fish demonstrates treatment-related chromosome damage in myeloid but not plasma cells in primary systemic amyloidosis","volume":"39","author":"Fonseca","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2012.05.003_bib32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0145-2126(02)00161-3","article-title":"Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia?","volume":"27","author":"Steensma","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2012.05.003_bib33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cancergencyto.2005.09.007","article-title":"Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia","volume":"165","author":"Trost","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.clml.2012.05.003_bib34","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1038\/sj.leu.2402713","volume":"16","author":"Mauritzson","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.05.003_bib35","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00277-008-0461-4","article-title":"Therapy-related patterns of cytogenetic abnormalities in acute myeloid leukemia and myelodysplastic syndrome post polycythemia vera: single center experience and review of literature","volume":"87","author":"Swolin","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2012.05.003_bib36","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/sj.leu.2401909","article-title":"Deletions of chromosome 13q in monoclonal gammopathy of undetermined significance","volume":"14","author":"K\u00f6nigsberg","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2012.05.003_bib37","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood.V100.4.1417.h81602001417_1417_1424","article-title":"Genomic abnormalities in monoclonal gammopathy of undetermined significance","volume":"100","author":"Fonseca","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib38","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1365-2141.2000.02488.x","article-title":"Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13","volume":"111","author":"Avet-Louseau","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2012.05.003_bib39","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V96.4.1505","article-title":"High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH","volume":"96","author":"Shaughnessy","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1046\/j.1365-2141.2002.03651.x","article-title":"Long-term follow up with conventional cytogenetics and band 13q14 interphase\/metaphase in situ hybridization monitoring in monoclonal gammopathies of undetermined significance","volume":"118","author":"Bernasconi","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2012.05.003_bib41","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1182\/blood.V99.6.2185","article-title":"Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation","volume":"99","author":"Avet-Loiseau","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib42","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1182\/blood.V98.4.1271","article-title":"The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance","volume":"98","author":"Fonseca","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clml.2012.05.003_bib43","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.3816\/CLM.2010.n.005","article-title":"The current status and future of multiple myeloma in the clinic","volume":"10","author":"Jagannath","year":"2010","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2012.05.003_bib44","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ajh.21285","article-title":"A novel report of cig-FISH and cytogenetics in POEMS syndrome","volume":"83","author":"Bryce","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2012.05.003_bib45","first-page":"4546","article-title":"14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma","volume":"59","author":"Avet-Loiseau","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.clml.2012.05.003_bib46","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2141.2007.06586.x","article-title":"Testing standard and genetic parameters in 220 patients with multiple myeloma with complete data sets: superiority of molecular genetics","volume":"137","author":"Shaughnessy","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2012.05.003_bib47","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","article-title":"Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du My\u00e9lome","volume":"26","author":"Decaux","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clml.2012.05.003_bib48","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3324\/haematol.11052","article-title":"Multiple myeloma primary cells show a highly rearranged unbalanced genome with amplifications and homozygous deletions irrespective of the presence of immunoglobulin-related chromosome translocations","volume":"92","author":"Largo","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2012.05.003_bib49","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1200\/JCO.2008.20.6136","article-title":"Prognostic significance of copy-number alterations in multiple myeloma","volume":"27","author":"Avet-Loiseau","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012000845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265012000845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:22:19Z","timestamp":1761870139000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265012000845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S2152265012000845"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2012.05.003","relation":{},"ISSN":["2152-2650"],"issn-type":[{"type":"print","value":"2152-2650"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Stratification of Plasma Cell Neoplasm: Insights From Plasma Cell\u2013Specific Cytoplasmic Immunoglobulin Fluorescence in Situ Hybridization (cIg FISH) vs. Conventional FISH","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2012.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}